Skip to content

Other

CYCLOPROPYLBIMATOPROST

CAS 1138395-12-6 Updated
8

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A close cousin of the prescription glaucoma drug bimatoprost. Used illegally in some lash serums; can darken iris, sink eyelids, and cause periorbital fat loss.

Function

ANTIOXIDANT

Skin benefits

  • No legitimate cosmetic benefit

Known concerns

  • Prostaglandin analog drug, not a cosmetic
  • Same class as bimatoprost (Latisse) prescription only
  • Eye risks: iris pigmentation change, periorbital fat loss, eyelid darkening
  • Not approved for OTC cosmetic use in EU
  • Adulteration concern in lash serums

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find CYCLOPROPYLBIMATOPROST in your products.

Scan any cosmetic product with LuxSense to see if it contains CYCLOPROPYLBIMATOPROST and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.